Publication | Open Access

Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway

InflammationSignal TransductionSignaling PathwayMedicineReceptor Tyrosine KinasePhysiologyVascular BiologyErk1/2 MapkPharmacologyCell BiologyCell SignalingCellular PhysiologyInsulin Signaling